SCHEMBL7594705

SCHEMBL7594705

c1coc(-c2nc3c4c[nH]nc4ncn3n2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.54
KDM4E B2RXH2 2/20 0.54
ALDH1A1 P00352 2/20 0.54
RAB9A P51151 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
NPC1 O15118 1/20 0.54
TP53 P04637 1/20 0.54
MAPT P10636 1/20 0.54
PPARG P37231 1/20 0.54
NCOA2 Q15596 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
RXFP1 Q9HBX9 1/20 0.54
CYP2C19 P33261 1/20 0.48
TSHR P16473 1/20 0.47
ADORA2A P29274 13/20 0.46
ADORA1 P30542 13/20 0.46
HPGD P15428 2/20 0.44
ADORA3 P0DMS8 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4758009 0.80 ADORA3 (0.63) HSD17B10KDM4EALDH1A1RAB9AMEN1
SCHEMBL2307829 0.79 ADORA3 (0.65) KDM4EKMT2AMAPTADORA2AADORA1
SCHEMBL4757988 0.77 ADORA2A (0.65) HSD17B10KDM4EALDH1A1RAB9AMEN1
SCHEMBL1665926 0.76 RAB9A (0.61) HSD17B10KDM4EALDH1A1RAB9AMEN1
SCHEMBL4759851 0.75 ADORA3 (0.67) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL4759525 0.75 ADORA2A (0.54) HSD17B10KDM4EALDH1A1RAB9AMEN1
SCHEMBL4758013 0.74 ADORA3 (0.68) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL30230665 0.73 ADORA2A (0.55) HSD17B10KDM4EALDH1A1RAB9AMEN1
SCHEMBL4759539 0.73 ADORA3 (0.68) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL4758535 0.73 ADORA3 (0.68) ADORA2AADORA1ADORA3ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448253-B1 Adenosine A3 receptor modulators KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. 2002-09-10 US claimed